Corrigendum to “Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.” [EClinicalMedicine 37 (2021) 100981]

Corrigendum to “Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.” [EClinicalMedicine 37 (2021) 100981]

Guardado en:
Detalles Bibliográficos
Autores principales: Vinicius Fontanesi Blum, MD, MSc, Sérgio Cimerman, MD, PhD, James R Hunter, PhD, Paulo Tierno, MD, Acioly Lacerda, Alexandre Soeiro, MD, Florentino Cardoso, MD, Nancy Cristina Bellei, PhD, MD, Juliana Maricato, PhD, Nathalia Mantovani, PhD, Marcella Vassao, MSc, Danilo Dias, Juliana Galinskas, Luis Mário Ramos Janini, MD, PhD, Joanna Reis Santos-Oliveira, PhD, Alda Maria Da-Cruz, MD, PhD, Ricardo Sobhie Diaz, MD, PhD
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Medicine (General)
R5-920
Acceso en línea:https://doaj.org/article/3db21fa89b734dc4a519f9cfbdb17eb7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares